Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL) News

Avadel Pharmaceuticals plc each representing one Ordinary Share (AVDL): $7.81

0.15 (+1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter AVDL News Items

AVDL News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AVDL News Highlights

  • AVDL's 30 day story count now stands at 3.
  • Over the past 14 days, the trend for AVDL's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest AVDL News From Around the Web

Below are the latest news stories about AVADEL PHARMACEUTICALS PLC that investors may wish to consider to help them evaluate AVDL as an investment opportunity.

Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates

- Adverse events were reported in patients who took the second, middle-of-the-night dose of immediate-release oxybate less than 2.5 hours after the first dose - DUBLIN, Ireland, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of real-world data describing the risk of accidental dosing errors with immediate-release twice-nightly oxybate. The paper, titled

Yahoo | January 24, 2023

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, Ireland, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to three (3) new employees to purchase an aggregate of 40,500 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employees’ acceptance of employment with Avadel

Yahoo | January 23, 2023

A stock that deserves closer examination: Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals plc (NASDAQ:AVDL) marked $6.99 per share on Monday, up from a previous closing price of $6.85. While Avadel Pharmaceuticals plc has overperformed by 2.04%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVDL fell by -2.65%, with highs and lows ranging from $10.02 to […]

US Post News | January 10, 2023

Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock: Boom Or Bust? What Happens Next?

During the last session, Avadel Pharmaceuticals plc (NASDAQ:AVDL)’s traded shares were 0.3 million, with the beta value of the company hitting 1.67. At the end of the trading day, the stock’s price was $7.16, reflecting an intraday gain of 3.77% or $0.26. The 52-week high for the AVDL share is $10.02, that puts it down … Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock: Boom Or Bust? What Happens Next? Read More »

Marketing Sentinel | December 31, 2022

Do investors need to be concerned about Avadel Pharmaceuticals plc (AVDL)?

Avadel Pharmaceuticals plc (NASDAQ:AVDL) closed Wednesday at $6.60 per share, down from $6.63 a day earlier. While Avadel Pharmaceuticals plc has underperformed by -0.45%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVDL fell by -17.29%, with highs and lows ranging from $10.02 to $1.05, whereas […]

US Post News | December 29, 2022

Avadel: Lumryz Overhang Now Removed, Rate Buy (NASDAQ:AVDL)

Avadel Pharmaceuticals is now in the pilot seat to steer the trajectory of its Lumryz formula. Read more to see why we rate AVDL stock a buy.

Seeking Alpha | December 7, 2022

Can you still get a good price for Avadel Pharmaceuticals plc (AVDL) Shares at this point?

A share of Avadel Pharmaceuticals plc (NASDAQ:AVDL) closed at $8.75 per share on Monday, down from $9.28 day before. While Avadel Pharmaceuticals plc has underperformed by -5.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AVDL rose by 7.49%, with highs and lows ranging from $10.02 […]

US Post News | December 6, 2022

Avadel stock surges 13% as Jefferies upgrades on opportunity to dent Jazz''s market share

Avadel Pharmaceuticals (AVDL) stock rose ~13% on Wednesday after Jefferies Financial upgraded the shares to Buy from Hold on opportunity of taking market share from Jazz…

Seeking Alpha | November 30, 2022

Avadel Pharmaceuticals plc (NASDAQ:AVDL) insiders placed bullish bets worth US$677k in the last 12 months

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | November 26, 2022

156K Reasons To Be Bullish On Avadel Pharmaceuticals Stock

Eric J Ende , Director at Avadel Pharmaceuticals (NASDAQ: AVDL ), reported a large insider buy on November 23, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Ende purchased 20,000 shares of Avadel Pharmaceuticals. The total transaction amounted to $156,050. Avadel Pharmaceuticals shares are trading down 2.13% at $7.81 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to … Full story available on Benzinga.com

Benzinga | November 24, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5881 seconds.